Switch Sponsors Weigh Business Opportunities Against Regulatory Risk
In 2020, the U.S. market saw four new brands previously sold as prescription drugs enter the nonprescription market: Pataday allergy eye drops Voltaren Arthritis Pain topical NSAID Advil Dual Action ibuprofen and acetaminophen pain reliever Sklice lice treatment The new switch approvals have signaled a willingness on the part of regulators to be less conservative when it comes to OTC access